Assessment of syndecan-1 (CD138) and Ki-67 expression for differentiating keratoacanthoma and squamous cell carcinoma
Lammoglia-Ordiales, L.; Toussaint-Caire, S.; Contreras-Barrera, M.; Fonte-Avalos, V.ón.; Rodriguez-Carreón, A.A.; Rivera-Macias, S.; Dominguez-Cherit, J.
Journal of Drugs in Dermatology Jdd 12(3): E53-E58
2013
ISSN/ISBN: 1545-9616 PMID: 23545927 Document Number: 17862
There is a major controversy over the natural behavior of keratoacanthoma (KA). KAs have been described as benign lesions, but also as variants of squamous cell carcinoma (SCC). Microscopic differentiation between these 2 entities is problematic, and sometimes impossible. Syndecan-1 (CD138) is an adhesion molecule whose expression appears to be inversely correlated with tumor invasiveness. Elevated Ki-67 expression is indicative of a high proliferation index, a feature of malignant tumors. Syndecan-1 and Ki-67 expression were assessed in 22 KA skin samples and in 17 SCC skin biopsies. Syndecan-1 expression was diminished in the SCC specimens compared with the KA specimens ( P =.000). Ki-67 expression was increased in the SCC specimens compared with the KA specimens, with mean values of 9 and 0.08, respectively ( P =.000). Further studies that compare intermediate risk KAs to typical KAs and SCCs are required to corroborate these findings. The assessment of syndecan-1 and Ki-67 expression in skin biopsies is a helpful tool for differentiating KA and SCC
Document emailed within 1 workday
